These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36748276)

  • 21. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function.
    Kreft ME; Jerman UD; Lasič E; Hevir-Kene N; Rižner TL; Peternel L; Kristan K
    Eur J Pharm Sci; 2015 Mar; 69():1-9. PubMed ID: 25555374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium.
    Yamada S; Noda T; Okabe K; Yanagida S; Nishida M; Kanda Y
    J Pharmacol Sci; 2022 Jul; 149(3):139-146. PubMed ID: 35641026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs.
    Sakagami M
    Adv Drug Deliv Rev; 2020; 161-162():63-74. PubMed ID: 32763274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C2-ceramide influences alveolar epithelial barrier function by downregulating Zo-1, occludin and claudin-4 expression.
    Yang J; Wang Y; Liu H; Bi J; Lu Y
    Toxicol Mech Methods; 2017 May; 27(4):293-297. PubMed ID: 28052715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of Protein Permeability and Fluid Transport of Human Alveolar Epithelial Type II Cells Under Pathological Conditions.
    Fang X; Matthay MA
    Methods Mol Biol; 2018; 1809():121-128. PubMed ID: 29987787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus.
    Murgia X; Yasar H; Carvalho-Wodarz C; Loretz B; Gordon S; Schwarzkopf K; Schaefer U; Lehr CM
    Eur J Pharm Biopharm; 2017 Sep; 118():79-88. PubMed ID: 28373109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of layers of the rat airway epithelial cell line RL-65 for permeability screening of inhaled drug candidates.
    Hutter V; Hilgendorf C; Cooper A; Zann V; Pritchard DI; Bosquillon C
    Eur J Pharm Sci; 2012 Sep; 47(2):481-9. PubMed ID: 22820031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier.
    Lehmann AD; Daum N; Bur M; Lehr CM; Gehr P; Rothen-Rutishauser BM
    Eur J Pharm Biopharm; 2011 Apr; 77(3):398-406. PubMed ID: 21056660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
    Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
    Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing.
    Tsuji K; Yamada S; Hirai K; Asakura H; Kanda Y
    J Toxicol Sci; 2021; 46(9):425-435. PubMed ID: 34470994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
    Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
    Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction.
    Hermanns MI; Kasper J; Dubruel P; Pohl C; Uboldi C; Vermeersch V; Fuchs S; Unger RE; Kirkpatrick CJ
    J R Soc Interface; 2010 Feb; 7 Suppl 1(Suppl 1):S41-54. PubMed ID: 19793744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells.
    Sasaki M; Kishimoto M; Itakura Y; Tabata K; Intaruck K; Uemura K; Toba S; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    Biochem Biophys Res Commun; 2021 Nov; 577():146-151. PubMed ID: 34517212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multiplex inhalation platform to model
    Sengupta A; Dorn A; Jamshidi M; Schwob M; Hassan W; De Maddalena LL; Hugi A; Stucki AO; Dorn P; Marti TM; Wisser O; Stucki JD; Krebs T; Hobi N; Guenat OT
    Front Pharmacol; 2023; 14():1114739. PubMed ID: 36959848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcellular Detection of SARS-CoV-2 RNA in Human Tissue Reveals Distinct Localization in Alveolar Type 2 Pneumocytes and Alveolar Macrophages.
    Acheampong KK; Schaff DL; Emert BL; Lake J; Reffsin S; Shea EK; Comar CE; Litzky LA; Khurram NA; Linn RL; Feldman M; Weiss SR; Montone KT; Cherry S; Shaffer SM
    mBio; 2021 Feb; 13(1):e0375121. PubMed ID: 35130722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rethinking of TEER measurement reporting for epithelial cells grown on permeable inserts.
    Karakocak BB; Keshavan S; Gunasingam G; Angeloni S; Auderset A; Petri-Fink A; Rothen-Rutishauser B
    Eur J Pharm Sci; 2023 Sep; 188():106511. PubMed ID: 37385303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology.
    Barilli A; Visigalli R; Ferrari F; Bianchi MG; Dall'Asta V; Rotoli BM
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19.
    Kryvenko V; Vadász I
    Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1186-L1193. PubMed ID: 33689516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.